Ganciclovir Implant Study for Cytomegalovirus Retinitis

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 1992

Study Completion Date

December 31, 1993

Conditions

HIV InfectionsAcquired Immunodeficiency SyndromeCytomegalovirus Retinitis

Interventions

DEVICE

Sustained-Release Intraocular Drug Delivery System

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00000118 - Ganciclovir Implant Study for Cytomegalovirus Retinitis | Biotech Hunter | Biotech Hunter